Table 2.
Demographic characteristics of idiopathic histaminergic acquired angioedema (IH‐AAE) patients
| Gender n (%) | ||
|---|---|---|
| Men | 15/31 (48·3%) | |
| Women | 16/31 (51·7%) | |
| Age | ||
| < 30 | 4/31 (12·9%) | |
| 30–60 | 17/31 (54·8%) | |
| > 60 | 10/31 (32·2%) | |
| Comorbidities | Specific treatments | |
| AHT | 7/31 (23%) |
ACE inhibitors: 5 patients perindopril: 2 enalapril: 2 ramipril: 1 Angiotensin receptor blockers: 3 patients candesartan: 2 valsartan: 1 |
| Diabetes | 4/31 (12·9%) | Gliptins: 0 patients |
| Asthma | 4/31 (12·9%) | |
| Allergic rhinitis | 9/31 (29%) | |
| Allergies – anaphylactic reactions | 4/31 (12·9%) | |
| Drug allergy | 1/31 | |
| Food allergy | 2/31 | |
| Stinging insect venom allergy | 1/31 | |
| Autoimmune thyroiditis | 1 | |
| Other autoimmune diseases | 0 | |
| Oncological diseases | 0 | |
ACE = angiotensin‐converting enzyme; AHT = arterial hypertension.